ArticleTaiwan journal of ophthalmology
Evaluation of dry eye parameters and meibomian gland loss in allergic rhinitis patients using ocular surface analyzer.
Article in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAllergic rhinitis (AR) is a common chronic inflammatory condition of the upper respiratory tract that can significantly diminish quality of life. AR contributes to dry eye disease (DED) and meibomian gland alterations due to ocular surface inflammation triggered by repeated exposure to environmental allergens. This study aims to evaluate DED and meibomian gland loss (MGL) in patients with AR. MATERIALS AND
methodsA comparative cross-sectional study was conducted involving 79 patients with AR at Hospital Universiti Sains Malaysia. The subjects underwent a detailed evaluation of dry eye parameters using noninvasive ocular surface analyzer including assessment of noninvasive tear breakup time (NIBUT), lipid layer thickness (LLT), and tear meniscus height (TMH). MGL was assessed by meibography. The results were compared with those of a control group of 81 age-matched healthy individuals without AR.
resultsPatients with AR showed statistically significantly lower NIBUT, LLT, and TMH values compared to the control group (
conclusionPatients with AR are at an increased risk of DED with a notable change in dry eye parameters and MGL. These findings underscore the importance of early detection and management of DED in patients with AR to prevent further ocular surface damage and improve their quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.